Free Newsletter
CDC lab inspection process under scrutiny
Over the course of three years, inspectors from the CDC found a raft of problems at Texas A&M's biodefense laboratory. Lethal agents and infected animals weren't properly guarded, unauthorized employees had access to infectious diseases and security measures were deemed inadequate. What they didn't find was evidence that workers had been exposed to Brucella, with one employee home sick during the 2006 CDC inspection. No one at the university alerted them to it, either. Those problems were exposed by an activist group, the Sunshine Project, raising questions about the effectiveness of the CDC's inspection process for the 350 labs it inspects throughout the U.S.
- see the findings from the Sunshine Project
- read the report from The Dallas Morning News
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: